autologous wt1-tcrc4 gene-transduced cd8-positive tcm/tn lymphocytes
Cell therapyexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started May 20, 2015 (NCT02408016)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Tumor antigensImmunity, passive
Tumor antigens immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- autologous wt1-tcrc4 gene-transduced cd8-positive tcm/tn lymphocytes
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02770820 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2018 | National Cancer Institute (NCI), University of Washington |
| NCT02408016 | Phase 1/Phase 2 (Phase 2) | May 20, 2015 | National Cancer Institute (NCI), University of Washington |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 2 | 0 | 1 | 2015 |
| University of Washington | Academic/Hospital | 2 | 2 | 1 | 2015 |
2 organizations
Page 1 / 1